City of Hope

www.cityofhope.org

 

City of Hope
J

Should Everyone Receive Monoclonal Antibodies at First Myeloma Relapse? No!

By City of Hope FEATURING Joseph Mikhael
By City of Hope FEATURING Joseph Mikhael
490 views
September 8, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey
Myeloma
11:43

Practical Perspectives on Recent CAR-T FDA Approvals in Myeloma

City of Hope

M. Janakiram

288 views
20:46

ASH 2022 Understanding and Monitoring Resistance to Anti-CD38 and -B…

ASH 2022 Conference Coverage

F. Pichiorri

203 views
07:29

ASCO 2021 Updated Phase 1 Results of Teclistamab, a B-Cell Maturatio…

City of Hope

A. Krishnan

124 views
18:44

The Promise of Immunotherapy and Newer Agents in Multiple Myeloma

City of Hope

A. Krishnan

495 views
17:58

Should Everyone Receive Monoclonal Antibodies at First Myeloma Relap…

City of Hope

J. Mikhael

490 views